| Name | sodium camptothecin |
|---|---|
| Synonyms |
camptothecinsodium
camptothecin,sodiumsalt 21,22-Secocamptothecin-21-oic acid,monosodium salt 20(S)-camptothecin sodium salt Fda 1660 21,22-secocamptothecin-21-oicacid,monosodiumsalt 20(s)-camptothecinsodiumsalt camptothecin Na camptothecinesodium CaMphotecin sodiuM |
| Description | Sodium Camptothecin is a plant alkaloid, with antitumor activity. Sodium Camptothecin is a reversible inhibitor of RNA synthesis. Sodium Camptothecin is an effective inhibitor of adenovirus replication. Sodium Camptothecin inhibits DNA synthesis and, intracellularly, causes breaks in preformed viral DNA[1][2]. |
|---|---|
| Related Catalog | |
| In Vitro | Sodium Camptothecin (5 μM; 10 min) causes a severe inhibition of heterogeneously sedimenting nuclear RNA (HnRNA) synthesis[1]. Sodium Camptothecin also blocks a specific step in the processing of ribosomal precursor RNA, allowing the conversion of 45S RNA to 32S RNA, but inhibiting the conversion of 32S RNA to 28S RNA [1]. |
| References |
| Boiling Point | 777.3ºC at 760 mmHg |
|---|---|
| Molecular Formula | C20H17N2NaO5 |
| Molecular Weight | 388.34900 |
| Flash Point | 423.9ºC |
| Exact Mass | 388.10400 |
| PSA | 115.48000 |
| LogP | 0.26500 |
| Vapour Pressure | 1.96E-25mmHg at 25°C |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
| Hazard Codes | T+ |
|---|---|
| HS Code | 2942000000 |
|
~97%
25387-67-1 |
| Literature: MediGene Oncology GmbH Patent: EP1547582 A1, 2005 ; Location in patent: Page/Page column 10 ; |
| Precursor 1 | |
|---|---|
| DownStream 0 | |
| HS Code | 2934999090 |
|---|---|
| Summary | 2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |